Prestige Estates Projects Q4 Profit Surges 10x to 250 Crore Amid Rangebound Stock Performance Torrent Pharma Reports 26 Drop in Q4 Profit Amid Acquisition Costs and QIP Approval SK Hynix Shatters Profit Records as AI Chip Demand Fuels Memory Boom AST SpaceMobile Gains as Market Approval Signals New Phase in Satellite Communications BHP Acknowledges Decarbonisation Delay as Western Australian Premier Emphasises Miners Moral Responsibility Motorsport Games Q1 2026 Earnings Unexpected Profitability Achieved Amidst Disclosed Challenges MGM Q1 2026 Earnings EPS Misses Estimates but Stock Gains Slightly CZNC Q1 2026 Earnings Massive EPS Miss as Earnings Plunge 966 Below Estimates United Rentals URI Q1 2026 Earnings Solid EPS Beat Powered by Operational Strength Catalyst Bancorp Inc CLST Q3 2025 Earnings EPS of 013 Reported Stock Remains Flat Vir Biotechnology VIR Bounces from Support Eyes Resistance at 965 AllianceBernstein National Municipal Income Fund AFB Advances 145 as Investors Seek TaxExempt Income Septerna Inc SEPN Surges 8 as Bullish Momentum Builds Western Asset Bond Fund WEA Holds Steady Near 1055 Amid Narrow Trading Range Beachbody Company BODI Slides 434 as Selling Pressure Intensifies MFS Municipal Income Trust MFM Holds Steady at 540 Consolidation Between Key Levels FAME Expands to Six New Chapters Strengthens AI Workforce Training in Manufacturing CHMI Q1 2026 Earnings Strong EPS Beat Amidst Challenging Mortgage Environment Heatwaves Expose Affordability Gap in Air Conditioning Market for Vulnerable Populations Apple Investors Eye June 18 as Potential Catalyst Date SMPL Q1 2026 Earnings EPS Surges Past Estimates with 118 Surprise Gladstone Investment Corp Notes GAING Eke Out Modest Gain as Bond Market Holds Steady NXDR Q1 2026 Earnings Narrower Loss Per Share Boosts Sentiment SVCO Q1 2026 Earnings EPS Beat Signals Cost Discipline Amidst Revenue Uncertainty FMBH Q1 2026 Earnings EPS Beats Estimates by 531 as Shares Rise CRVL Q1 2026 Earnings EPS of 061 Exceeds Expectation Stock Declines 269 AGM Q1 2026 Earnings Strong EPS Beat Driven by Core Operations Symbotic Q1 2026 Earnings EPS Misses Estimates as Stock Rises on Growth Optimism Recursion Pharmaceuticals Q1 2026 Earnings Narrowed Loss Beats Estimates Amid Pipeline Progress